Pediatric Delirium in 2023: Keeping Your Practice Current

Author(s): Jodi Mullen

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.30

Expires Oct 15, 2026

Topics: Delirium, Pharmacology

Population: Pediatric

Role: APRN

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Delirium affects at least 30% of hospitalized pediatric patients and contributes to increased length of stay, ventilator days, mortality and costs, and may have long term sequalae, but less than 40% of ICUs consistently screen patients for delirium. This advanced session includes pathophysiology, clinical features, and modifiable factors which can contribute to delirium development. Attendees improve their knowledge of screening tools, risk factors and interventions for delirium prevention and management while diagnosing and managing several interactive case studies. All leave with resources to maximize their own unit’s processes for delirium recognition and intervention.

Objectives

  • Identify risk factors for the development of delirium in infants and children.
  • Employ pediatric delirium screening and prevention into routine clinical practice.
  • Analyze pharmacologic and non-pharmacologic interventions to prevent and manage delirium in children.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.